Dennis Fenton

Dennis Fenton, Ph.D., is the owner and chief executive officer of Fenton and Associates, a biotechnology consulting firm. Prior to founding Fenton and Associates, Dr. Fenton served as executive vice president of operations at Amgen, where he was responsible for worldwide operations, manufacturing, process development, and quality. Dr. Fenton joined Amgen in 1982 and held numerous executive leadership roles in operations and sales and marketing. In addition to Portola, he serves on the board of Sienna and AnaptysBio. He also serves on the board of the Keck Graduate Institute. He previously served on the boards of Kythera, Hospira, Dendreon, Xenoport, and Genzyme. He received a B.S. from Manhattan College and a Ph.D. in microbiology from Rutgers University.